Lung Cancer Clinical Trials in Austin, TX

Lung Cancer Clinical Trials in Austin, TX

View the best 10 lung cancer medical studies in Austin, Texas. Access promising new therapies by applying to a Austin-based Lung Cancer clinical trial.

Trials in Austin, Texas

Here are the top 10 medical studies for lung cancer in Austin, Texas

Image of Research Site in La Jolla, United States.

Carboplatin +5 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial tests if two drugs plus chemo work better than one drug plus chemo to treat metastatic lung cancer with gene mutations.
Image of Christ Hospital Cancer Center in Cincinnati, United States.

RMC-6236

Small Molecule Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug called RMC-6236, which is taken by mouth and targets a protein called RAS. It is aimed at adults with advanced cancers that have specific mutations in the RAS protein. The drug works by blocking this protein, which helps stop the cancer cells from growing.
Image of Exelixis Site #1 in Tucson, United States.

XL092

Recruiting1 awardPhase 1
This trial is testing a new drug called XL092 alone and with other cancer drugs in patients with advanced solid tumors. The goal is to see if these treatments can safely stop or slow tumor growth and help the immune system fight cancer more effectively.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of Washington University School of Medicine - Siteman Cancer Center,Substudy-01 in Saint Louis, United States.

Carboplatin +9 More

Platinum-based Chemotherapy

Recruiting1 awardPhase 2
This trial is testing new treatment combinations for lung cancer to see if they work better than current treatments. It focuses on patients with advanced or resectable lung cancer, including those who haven't been treated before or whose cancer has worsened after treatment. The goal is to find out if these new combinations can shrink or eliminate tumors more effectively.
Image of Arizona Oncology Associates, PC - HOPE in Tucson, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer, including metastatic cancer that has progressed after PD-1 inhibitor treatment. The study will also find out what side effects occur.
Image of NEXT Oncology in Austin, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests a new drug, BDC-3042, as a stand-alone treatment and combined with pembrolizumab to treat advanced cancers.
Image of Research Site in Springdale, United States.

Carboplatin +4 More

Chemotherapy

Recruiting2 awardsPhase 3
This trial is testing a new drug, rilvegostomig, in combination with chemotherapy for patients with a specific type of lung cancer that has spread.
Image of University of South Alabama /ID# 212939 in Mobile, United States.

Telisotuzumab Vedotin

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial tests telisotuzumab vedotin, a treatment that targets and kills cancer cells, in NSCLC patients with high c-Met levels. It aims to find the best patient group for this therapy and evaluate its safety and effectiveness. Telisotuzumab vedotin is a specialized treatment targeting c-Met-overexpressing tumor cells, and it has been evaluated in various studies for its safety and efficacy in treating advanced solid tumors, including non-small cell lung cancer.
Image of Research Site in Mesa, United States.

Durvalumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 3
This trial is testing a new immunotherapy drug combo to see if it's more effective than just one of the drugs for treating lung cancer that has spread and can't be removed by surgery.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.